Related content

CD4⁺ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25⁺ T cells

By Elkord Eyad   Burt Deborah   Drijfhout Jan   Hawkins Robert   Stern Peter  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 6, 2008-06 ,pp. : 833-847

Springer Publishing Company

Access to resources Recommend Favorite

Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice

By            

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 3073-3080

Spandidos Publications

Access to resources Recommend Favorite

Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy

By Ruiz-Cabello F.   Cabrera T.   Lopez-Nevot M-A.   Garrido F.  

Seminars in Cancer Biology, Vol. 12, Iss. 1, 2002-02 ,pp. : 403-405

Academic Press

Access to resources Recommend Favorite

Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Iss. 3, 2013-09 ,pp. : 239-254

Bentham Science Publishers

Access to resources Recommend Favorite

Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy

By Merrick Alison   Diaz Rosa   O’Donnell Dearbhaile   Selby Peter   Vile Richard   Melcher Alan  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 6, 2008-06 ,pp. : 897-906

Springer Publishing Company

Access to resources Recommend Favorite